foodborn
ill
seriou
public
health
concern
known
microbi
chemic
physic
agent
known
caus
foodborn
ill
effort
made
improv
detect
control
prevent
foodborn
pathogen
food
pathogen
associ
diseas
host
sever
commonli
use
approach
control
foodborn
pathogen
includ
antibiot
natur
antimicrobi
bacteriophag
bacteriocin
ioniz
radiat
heat
addit
probiot
offer
potenti
intervent
strategi
prevent
control
foodborn
infect
review
focus
use
probiot
bioengin
probiot
control
foodborn
pathogen
antimicrobi
action
deliveri
strategi
although
probiot
demonstr
effect
antagon
foodborn
pathogen
challeng
exist
character
elucid
underli
molecular
mechan
action
develop
potenti
deliveri
strategi
could
maintain
viabil
function
probiot
target
organ
foodborn
ill
seriou
public
health
concern
global
burden
foodborn
ill
current
unknown
howev
world
health
organ
report
million
peopl
die
diarrheal
diseas
larg
due
contamin
food
water
greig
ravel
newel
et
al
unit
state
center
diseas
control
prevent
cdc
estim
year
million
case
foodborn
infect
hospit
death
scallan
et
al
known
microbi
chemic
physic
agent
result
ill
consum
newel
et
al
microbi
sourc
compris
bacteri
viral
fungal
major
concern
cdc
estim
foodborn
infect
hospit
death
attribut
known
pathogen
scallan
et
al
light
seriou
public
health
crisi
effort
direct
toward
detect
control
prevent
wellrecogn
foodborn
pathogen
diseas
food
chain
estim
reduct
foodborn
ill
would
keep
million
american
get
sick
year
scallan
et
al
increas
trend
consum
prefer
safe
wholesom
food
probiot
offer
effect
altern
intervent
strategi
control
foodborn
ill
pathogen
includ
noroviru
nontyphoid
salmonella
clostridium
perfringen
campylobact
spp
staphylococcu
aureu
pathogen
enter
food
system
contamin
raw
materi
water
human
meat
anim
wild
life
insect
vector
sever
factor
affect
trend
occurr
foodborn
ill
largescal
product
wide
distribut
food
global
food
suppli
eat
outsid
home
microbi
genom
diversif
yield
emerg
new
pathogen
grow
popul
atrisk
consum
diseas
caus
pathogen
differ
consequ
sequel
tabl
foodborn
pathogen
sicken
million
american
annual
us
popul
scallan
et
al
reduc
foodborn
ill
would
keep
million
american
get
sick
everi
year
food
safeti
concern
also
elev
consum
demand
high
qualiti
low
preserv
minim
process
conveni
readytoeat
meal
food
highli
vulner
contamin
heighten
public
health
safeti
concern
led
develop
sever
control
strategi
govern
industri
strategi
control
foodborn
infect
classifi
preharvest
postharvest
intervent
tradit
much
research
effort
aim
improv
safeti
meat
product
postslaught
sanit
product
formul
howev
continu
incid
outbreak
increas
knowledg
pathogen
led
develop
preharvest
intervent
strategi
doyl
erickson
preharvest
intervent
step
logic
food
safeti
approach
allow
reduc
level
pathogen
load
incom
raw
materi
callaway
anderson
et
al
soon
chadd
bain
antibiot
known
alter
microbiolog
ecolog
intestin
tract
led
prophylact
use
antibiot
anim
agricultur
control
diseas
improv
anim
growth
rate
effici
emerg
antibiot
resist
among
pathogen
research
focus
use
natur
occur
antimicrobi
altern
control
foodborn
pathogen
live
anim
food
antimicrobi
compris
organ
acid
essenti
oil
plant
extract
bacteriocin
probiot
bacteriophag
baugher
klaenhamm
callaway
anderson
et
al
hassan
kjo
ne
diep
lotfipour
negi
chemic
rins
use
organ
acid
gener
recogn
safe
acet
lactic
citric
acid
commonli
use
meat
industri
rins
anim
carcass
produc
fruit
veget
sirsat
muthaiyan
rick
acid
reduc
ph
food
henc
control
growth
microorgan
lactic
acid
effect
appli
higher
temperatur
concentr
sirsat
et
al
organ
acid
sometim
use
combin
oxid
agent
hydrogen
peroxid
enhanc
antimicrobi
efficaci
essenti
oil
extract
clove
cinnamon
thyme
oregano
compon
use
control
foodborn
pathogen
nontyphoid
salmonella
johni
hoagland
venkitanarayanan
escherichia
coli
amalaradj
et
al
listeria
monocytogen
microbiolog
growth
media
live
anim
food
system
hyldgaard
mygind
meyer
unlik
antibiot
essenti
oil
multifacet
antimicrobi
effect
therebi
make
difficult
bacteria
develop
resist
microbi
contamin
also
control
use
microbicid
treatment
ioniz
radiat
heat
applic
nontherm
method
high
hydrostat
pressur
highintens
puls
electr
field
oscil
magnet
field
intens
light
puls
photosensit
combin
hurdl
approach
also
shown
effect
zukauska
morri
brodi
wicker
one
common
physic
method
decontamin
irradi
radomyski
murano
olson
murano
smith
pillai
food
irradi
destroy
indigen
flora
prolong
shelf
life
product
storag
food
expos
dose
ioniz
radiat
suffici
enough
creat
posit
neg
charg
kill
bacteria
food
type
physic
method
use
dosag
treatment
depend
type
food
matrix
decontamin
biolog
method
control
includ
use
bacteriophag
bacteriocin
probiot
food
matrix
compon
present
natur
ad
extrins
biolog
agent
use
preand
postharvest
phase
prevent
bacteri
contamin
hagen
loessner
bacteriophag
virus
infect
kill
bacteria
consid
altern
antimicrobi
use
food
industri
obeso
therapeut
applic
treat
diseas
fischetti
fischetti
hanlon
howev
bacteriophag
narrow
target
spectra
use
particular
strain
high
degre
specif
allow
phage
use
target
microorgan
mix
popul
without
affect
microbi
ecosystem
callaway
anderson
et
al
bacteriophag
use
control
foodborn
pathogen
farm
anim
specif
pathogen
hagen
loessner
lejeun
wetzel
wall
zhang
rostagno
ebner
addit
sever
phage
phage
cocktail
approv
fda
use
modern
approach
probiot
research
control
foodborn
pathogen
food
addit
readytoeat
meat
applic
cattlepoultri
prior
slaughter
hagen
loessner
use
probiot
prebiot
synbiot
combin
prebiot
probiot
also
gain
increas
attent
recent
year
use
microflora
reduc
pathogen
load
gut
term
probiot
strategi
callaway
anderson
et
al
probiot
techniqu
involv
introduct
normal
microbi
popul
gut
provid
nutrient
prebiot
limit
allow
growth
specif
subset
gut
microflora
goal
approach
fill
nich
avail
gut
exclud
establish
pathogen
microb
doyl
erickson
gaggia
mattarelli
biavati
patterson
burkhold
due
increas
concern
emerg
antibiot
resist
use
probiot
provid
effect
altern
combat
foodborn
ill
baugher
klaenhamm
dobson
cotter
ross
hill
hassan
et
al
addit
vaccin
antibodi
therapi
also
offer
viabl
option
reduc
burden
foodborn
ill
vaccin
therapi
involv
stimul
anim
immun
system
limit
pathogen
colon
two
type
vaccin
employ
immun
food
anim
use
kill
inactiv
bacteri
cell
live
attenu
cell
approach
use
poultri
reduc
colon
salmonella
use
salmonellaspecif
antibodi
de
buck
van
immerseel
haesebrouck
ducatel
tellez
et
al
similar
approach
cattl
swine
shown
promis
result
enhanc
immunoglobulin
iga
igg
igm
serum
reduc
pathogen
carriag
hous
bishop
parri
dougan
wain
mastroeni
chabalgo
dunstan
maskel
dougan
along
intervent
strategi
good
anim
manag
good
agricultur
practic
equal
crucial
product
healthi
anim
agricultur
product
ensur
food
safeti
antibiot
wide
use
anim
agricultur
control
diseas
increas
anim
growth
rate
effici
although
antibiot
use
target
specif
bacteria
specif
sometim
narrow
highli
effect
therefor
sever
occas
broadspectrum
antibiot
often
includ
anim
ration
treatment
disrupt
intestin
microbi
ecosystem
lead
establish
opportunist
pathogen
could
also
impos
deleteri
effect
anim
health
perform
food
safeti
addit
use
antibiot
human
veterinari
medicin
treat
infecti
diseas
led
rise
spread
antibiot
resist
callaway
anderson
et
al
increas
antibioticresist
strain
pose
signific
public
health
hazard
yield
increas
frequenc
treatment
failur
sever
infect
prolong
durat
sick
increas
system
infect
increas
hospit
mortal
newel
et
al
antibiot
use
plant
anim
human
healthpromot
purpos
lead
emerg
dissemin
resist
bacteria
resist
gene
sinc
antibiot
resist
spread
horizont
use
antibiot
one
ecolog
compart
consequ
resist
statu
anoth
kruse
sorum
newel
et
al
food
plant
anim
origin
sourc
antibioticresist
bacteria
resist
gene
presenc
antibioticresist
bacteria
food
present
direct
hazard
food
handler
consum
equal
addit
resist
trait
transfer
bacteria
food
origin
human
pathogen
directli
via
commens
result
indirect
hazard
newel
et
al
addit
antimicrobi
resist
also
aris
due
continu
exposur
bacteria
antimicrobi
residu
food
furthermor
differ
rout
bacteria
acquir
resist
complex
increas
evid
incid
antibioticresist
bacteria
food
highlight
import
antibioticresist
foodborn
pathogen
infect
sever
antibioticresist
strain
salmonella
threlfal
campylobact
faowhooi
shigella
vibrio
aureu
de
boer
et
al
e
coli
walsh
et
al
enterococci
faowhooi
report
food
plant
anim
origin
newel
et
al
sever
strain
also
report
multidrug
resist
infect
caus
strain
import
health
problem
import
step
curb
antimicrobi
resist
enforc
prudent
use
antimicrobi
agent
sector
anim
food
product
faowhooi
employ
altern
strategi
control
food
pathogen
present
interrelationship
diet
health
well
establish
tradit
role
diet
provid
nutrient
essenti
metabol
howev
last
decad
idea
evolv
establish
besid
meet
metabol
need
diet
also
help
promot
health
state
wellb
individu
chang
concept
dietari
role
food
led
develop
new
class
dietari
product
call
function
food
food
consid
function
benefici
affect
target
function
bodi
besid
nutrit
valu
figueroagonzalez
quijano
ramirez
cruzguerrero
probiot
fall
categori
function
food
nagpal
et
al
nonpathogen
microorgan
confer
health
benefit
host
prevent
diseas
administ
adequ
amount
fric
wide
use
probiot
includ
lactobacilli
bifidobact
bacilli
yeast
nonpathogen
speci
within
genera
escherichia
ie
e
coli
nissl
enterococcu
bacillu
howev
common
probiot
belong
genera
lactobacillu
bifidobacterium
probiot
gener
exert
benefici
effect
three
way
provid
end
product
anaerob
ferment
carbohydr
organ
acid
util
host
end
product
absorb
blood
stream
abl
influenc
human
mood
energi
level
even
cognit
abil
ii
effect
compet
pathogen
colon
exclud
caus
diseas
iii
stimul
host
immun
system
produc
specif
polysaccharid
health
benefit
gener
strain
specif
speciesor
genera
specif
thu
case
cocktail
probiot
use
gain
benefit
probiot
cocktail
also
ensur
health
benefit
event
one
strain
fail
control
foodborn
pathogen
probiot
either
use
competit
exclus
defin
cultur
competit
exclus
involv
extrins
administr
probiot
food
anim
intestin
colon
probiot
bacteria
also
affect
composit
function
intestin
microbi
popul
otool
cooney
predomin
presenc
probiot
gut
prevent
pathogen
access
ecolog
nich
interf
attach
pathogen
gut
subvert
eventu
infect
process
gaggia
et
al
besid
physic
displac
pathogen
sever
probiot
also
produc
bacteriocin
antimicrobi
peptid
inactiv
pathogen
addit
probiot
stimul
immun
system
help
mount
protect
respons
pathogen
interact
host
cell
gill
prasad
probioticinduc
enhanc
butyr
product
also
increas
resist
diseas
activ
antimicrobi
host
defens
peptid
floch
sunkara
et
al
although
use
probiot
promis
sever
challeng
industri
product
probioticbas
function
food
improv
product
techniqu
largescal
manufactur
ii
costeffect
product
strategi
iii
enhanc
probiot
viabil
storag
manufactur
transit
gastrointestin
tract
iv
develop
effici
deliveri
system
strategi
overcom
challeng
must
multidisciplinari
help
make
process
costeffect
benefici
produc
consum
bacteria
deliber
ad
food
either
enhanc
product
flavor
starter
cultur
enhanc
health
benefit
function
addit
probiot
bacteria
use
prevent
treatment
variou
diseas
thu
probiot
organ
must
nonpathogen
host
prior
consider
use
commonli
use
probiot
bacteria
includ
member
genera
lactococcu
lactobacillu
bifidobacterium
lactic
acid
bacteria
gener
consid
safe
howev
speci
lactobacillu
bacillu
associ
opportunist
infect
patient
underli
condit
result
endocard
bacteremia
liver
abscess
boyl
robinsbrown
tang
presum
pathogen
properti
associ
specif
strain
rather
speci
gener
thu
strainspecif
character
essenti
prove
absenc
pathogen
prior
approv
probiot
human
use
essenti
bacteria
screen
potenti
pathogen
virul
trait
sander
et
al
provid
evid
absenc
virul
properti
rel
straightforward
elucid
pathogen
potenti
besid
phenotyp
character
also
essenti
genet
screen
potenti
candid
use
probiot
anoth
critic
consider
scope
antimicrobi
resist
addit
sensit
antibiot
also
essenti
probiot
bacteria
carri
transferr
antibiot
resist
gene
serv
genet
reservoir
potenti
pathogen
bacteria
besid
acquisit
antibioticresist
gene
also
risk
uptak
virul
gene
pathogen
coinhabit
intestin
tract
time
howev
evid
literatur
event
take
place
gut
could
partli
due
transient
colon
gut
probiot
scientif
committe
anim
nutrit
scan
establish
guidelin
decis
tree
fig
approv
probiot
strain
base
antibiot
resist
scan
similar
screen
strategi
also
employ
approv
probiot
strain
use
feed
addit
consid
factor
essenti
assess
safeti
probiot
paramount
gener
conclus
probiot
safe
broadli
made
prior
use
probiot
probiot
cocktail
food
dietari
supplement
need
determin
safe
gener
popul
intend
use
drug
safeti
assess
must
balanc
risk
benefit
sander
et
al
fao
outlin
guidelin
approv
probiot
strain
use
food
fig
term
probiot
mean
life
associ
bacteria
exert
benefici
effect
human
anim
first
observ
eli
metchnikoff
suggest
depend
intestin
microb
food
make
possibl
develop
measur
modifi
gut
flora
replac
harm
microb
use
microb
initi
work
e
metchnikoff
h
tissier
earli
twentieth
centuri
set
stage
elucid
benefici
effect
probiot
multitud
applic
human
health
summar
recent
review
articl
bron
van
baarlen
kleerebezem
increas
bodi
scientif
evid
demonstr
benefici
effect
probiot
health
diseas
prevent
treatment
made
probiot
increasingli
import
part
human
nutrit
led
surg
demand
probiot
clinic
applic
deshpand
rao
patol
ng
hart
kamm
stagg
knight
vanderpool
yan
polk
function
food
ly
litonjua
gold
celedon
nagpal
et
al
probiot
defin
base
intent
use
fuller
defin
probiot
live
microbi
feed
supplement
benefici
affect
host
anim
improv
intestin
balanc
definit
genu
speci
strain
deposit
intern
cultur
collect
vitro
test
vitro
andor
anim
model
anim
studi
phase
highlight
microbi
natur
probiot
similarli
hui
nt
veld
havenaar
marteau
defin
probiot
viabl
mono
mix
cultur
bacteria
appli
anim
man
benefici
affect
host
improv
properti
indigen
flora
recent
definit
accept
faowho
defin
probiot
live
microorgan
administ
adequ
amount
confer
health
benefit
host
definit
tend
reiter
basic
definit
probiot
live
microorgan
adequ
dose
benefici
human
probiot
classifi
base
abil
colon
intestin
resid
transient
resid
strain
common
inhabit
human
digest
tract
probiot
supplement
contain
strain
abl
reestablish
intestin
tract
resid
strain
may
least
antagonist
effect
benefici
resid
strain
intestin
tract
transient
strain
pass
system
reestablish
certain
transient
strain
may
effect
use
monocultur
henc
case
combin
resid
strain
enhanc
efficaci
taxonom
probiot
must
identifi
genu
speci
strain
done
bacteria
commonli
use
probiot
includ
member
genu
lactobacillu
bifidobacteria
streptococcu
enterococcu
leuconostoc
yeast
saccharomyc
among
resid
strain
includ
lactobacillu
acidophilu
lactobacillu
salivariu
bifidobacterium
bifidum
bifidobacterium
infanti
bifidobacterium
longum
bifidobacterium
animali
streptococcu
faecali
streptococcu
faecium
transient
strain
includ
lactobacillu
casei
lactobacillu
rhamnosu
gg
lactobacillu
bulgaricu
lactobacillu
yoghurti
lactobacillu
brevi
lactobacillu
kefir
lactobacillu
delbrueckii
lactobacillu
plantarum
streptococcu
lacti
streptococcu
thermophilu
bacteria
possess
certain
characterist
identifi
probiot
tabl
list
criteria
essenti
bacterium
classifi
probiot
abl
produc
desir
benefici
effect
establish
dose
billion
coloni
form
unitday
recommend
least
day
gronlund
lehtonen
eerola
kero
william
probiot
either
mono
mix
cultur
mainli
consist
lactobacilli
use
human
consumpt
varieti
food
ferment
milk
yogurt
chess
fruit
juic
chocol
wine
sausag
mix
cultur
highli
desir
may
synergist
effect
moreov
one
fail
other
still
exert
benefici
effect
well
establish
probiot
sever
benefici
attribut
dick
bote
nagpal
et
al
william
includ
lactos
metabol
food
digest
product
antimicrobi
peptid
control
enter
infect
antimycot
effect
anticarcinogen
properti
immunolog
enhanc
enhanc
shortchain
fatti
acid
scfa
product
antiatherogen
cholesterollow
attribut
regulatori
role
allergi
thoma
et
al
protect
vagin
urinari
tract
infect
increas
nutrit
valu
mainten
epitheli
integr
barrier
stimul
repair
mechan
cell
mainten
reestablish
wellbalanc
indigen
intestin
respiratori
microbi
commun
sever
mechan
propos
regard
action
probiot
major
attribut
discuss
tabl
intestin
barrier
function
import
defens
mechan
intestin
epithelium
maintain
protect
effect
protect
invad
pathogen
harm
agent
ohland
macnaughton
barrier
function
maintain
sever
mechan
includ
mucu
secret
chlorid
water
secret
mainten
cellcel
tight
junction
thoma
ockhuizen
disrupt
barrier
tabl
criteria
ideal
probiot
accur
taxonom
identif
normal
inhabit
target
speci
gener
recogn
safe
resist
bile
hydrochlor
acid
pancreat
juic
abil
surviv
acid
condit
stomach
alkalin
condit
intestin
abil
persist
gut
even
colon
adhes
epithelium
prevent
physic
remov
immunostimulatori
action
nonpathogen
maintain
high
cell
viabil
metabol
activ
target
site
stabil
desir
characterist
process
storag
deliveri
genet
stabil
nagpal
et
al
function
lead
variou
condit
inflammatori
bowel
diseas
ibd
coeliac
diseas
enter
infect
autoimmun
diseas
ng
et
al
sever
probiot
shown
protect
epitheli
barrier
prevent
mucos
damag
trigger
food
antigen
enter
pathogen
drug
proinflammatori
cytokin
ohara
shanahan
protect
effect
mediat
sever
mechan
either
directli
indirectli
alter
gut
microflora
popul
first
barrier
intestin
bacteria
pathogen
meet
mucu
entir
length
intestin
tract
line
goblet
cell
percent
goblet
cell
increas
duodenum
descend
colon
rel
epitheli
cell
goto
kiyono
intestin
microflora
also
regul
goblet
cell
popul
gut
goblet
cell
secret
mucin
resist
proteolysi
form
protect
gel
layer
epitheli
surfac
intestin
bacteria
pathogen
penetr
mucu
layer
reach
epitheli
cell
infect
sever
microorgan
develop
divers
method
degrad
mucu
either
aid
invas
uptak
mucusderiv
nutrient
aristot
willcox
ohland
macnaughton
addit
sever
studi
also
report
mucu
layer
significantli
thinner
area
inflamm
thu
compromis
barrier
allow
increas
bacteri
adher
infiltr
swidsinski
et
al
probiot
enhanc
barrier
promot
mucu
secret
sever
lactobacillu
speci
increas
mucin
express
vitro
cell
cultur
model
block
pathogen
e
coli
adher
invas
mack
ahrn
hyde
wei
hollingsworth
similarli
vivo
experi
rat
fed
probiot
cocktail
vsl
day
demonstr
signific
increas
mucin
secret
caballerofranco
keller
de
simon
chade
thu
enhanc
mucu
product
probiot
vitro
vivo
could
use
protect
strategi
augment
intestin
barrier
function
bacteria
come
across
mucu
layer
find
bind
site
epithelium
colonizationattach
pathogen
bacteria
howev
proceed
penetr
damag
epithelium
caus
diseas
enterocyt
express
pattern
recognit
receptor
tolllik
receptor
tlr
sens
presenc
conserv
bacteri
motif
initi
cascad
proinflammatori
signal
franchi
wamer
viani
nunez
receptor
present
intracellularli
basolater
enterocyt
therefor
pathogen
breach
barrier
come
contact
receptor
differenti
commens
modern
approach
probiot
research
control
foodborn
pathogen
pathogen
bacteria
gut
franchi
et
al
franklin
latz
enterocyt
cellcel
adhes
essenti
compon
intestin
barrier
sever
compon
make
cellcel
junction
complex
tight
junction
adheren
junction
gap
junction
desmosom
turner
intercellular
junction
complex
help
maintain
epitheli
barrier
permeabl
integr
groschwitz
hogan
marchiando
graham
turner
ohland
macnaughton
regul
tight
junction
associ
epitheli
permeabl
essenti
maintain
epitheli
barrier
function
howev
pathogen
evolv
differ
mechan
cross
epitheli
barrier
demonstr
critic
role
barrier
play
mainten
homeostasi
prevent
inflamm
goto
kiyono
chronic
inflamm
shown
associ
alter
tight
junction
barrier
function
promot
pathogen
access
basolater
side
epitheli
barrier
sever
studi
demonstr
pretreat
probiot
bacteria
inhibit
loss
permeabl
associ
tight
junction
alter
caus
stress
infect
proinflammatori
cytokin
aitbelgnaoui
et
al
dahan
et
al
ewaschuk
et
al
sherman
et
al
shown
probiot
directli
alter
epitheli
barrier
function
alter
structur
function
tight
junction
restalenert
barrett
barrett
found
pretreat
thermophilu
l
acidophilu
independ
decreas
permeabl
cell
monolay
form
intestin
cell
studi
also
demonstr
probiot
alter
express
sever
protein
structur
compon
tight
junction
therebi
decreas
permeabl
anoth
studi
yan
et
al
demonstr
certain
protein
produc
probiot
bacteria
interact
mammalian
cell
signal
protein
lead
alter
tight
junction
function
permeabl
two
protein
produc
l
rhamnosu
inhibit
apoptosi
enterocyt
promot
surviv
addit
protein
also
alter
structur
compon
cell
junction
complex
enhanc
barrier
function
tabl
intestin
first
site
foreign
antigen
encount
therefor
intestin
develop
tightli
regul
mechan
protect
pathogen
invas
intestin
immun
system
made
sever
seth
yan
polk
rao
lymphoid
organ
collect
call
gutassoci
lymphoid
tissu
largest
collect
lymphoid
tissu
bodi
consist
mesenter
lymph
node
peyer
patch
isol
lymphoid
follicl
lymphocyt
dendrit
cell
forchielli
walker
hakansson
molin
newberri
lorenz
microbi
colon
gut
affect
composit
immun
cell
popul
sever
studi
demonstr
bacteri
colon
gut
led
increas
number
intraepitheli
lymphocyt
germin
center
antibodyproduc
cell
serum
antibodi
concentr
hakansson
molin
demonstr
complex
relationship
exist
intestin
immun
system
gut
microbiota
bron
et
al
sever
vivo
vitro
studi
demonstr
immunostimulatori
effect
probiot
intestin
immun
system
gill
prasad
probiot
probioticsderiv
product
detect
special
membran
cell
cell
antigen
taken
cell
process
antigenprocess
cell
apc
present
cell
type
cytokin
secret
phenotyp
activ
apc
determin
lineag
cell
produc
name
helper
helper
regulatori
treg
cell
activ
cell
lead
product
ifng
tnfa
lead
develop
cellmedi
cytotox
immun
cell
activ
apc
mainli
secret
promot
antibodi
product
treg
cell
secret
tgfb
downregul
activ
cell
help
maintain
homeostasi
intestin
gill
prasad
probiot
demonstr
modul
innat
acquir
immun
respons
innat
immun
system
form
first
line
defens
pathogen
major
compon
innat
immun
system
includ
epitheli
cell
phagocyt
cell
monocyt
macrophag
neutrophil
natur
killer
cell
sever
clinic
trial
demonstr
probiot
enhanc
phagocyt
activ
peripher
blood
leukocyt
gill
healthi
subject
administ
l
johnsonii
l
rhamnosu
b
lacti
demonstr
enhanc
phagocyt
capac
peripher
blood
leukocyt
increas
phagocyt
abil
also
found
dose
depend
last
sever
week
cessat
probiot
intak
gill
rutherfurd
probiot
also
activ
neutrophil
increas
express
phagocytosi
receptor
pelto
isolauri
liliu
nuutila
salminen
increas
oxid
burst
microbicid
capac
leukocyt
parra
de
morentin
cobo
mateo
martinez
similarli
consumpt
probiot
healthi
subject
led
increas
number
activ
nk
cell
increas
phagocyt
action
anim
fed
probiot
supplement
cross
probioticmedi
gut
health
attribut
stimul
epitheli
innat
immun
administr
probiot
mixtur
vsl
exhibit
antiinflammatori
effect
stimul
epithelialderiv
tnfa
product
activ
nfkb
pagnini
et
al
besid
modul
innat
immun
respons
probiot
also
shown
augment
acquir
immun
respons
induct
cellmedi
immun
intak
probiot
led
increas
antibodi
respons
natur
infect
immun
random
trial
children
rotaviru
administ
l
rhamnosu
gg
demonstr
increas
specif
mucos
serum
antibodi
respons
kaila
et
al
similarli
administr
probiot
follow
immun
salmonella
vaccin
subject
led
significantli
higher
specif
serum
iga
igamedi
cell
respons
linkamst
rochat
saudan
mignot
aeschlimann
observ
indic
probiot
strain
exhibit
adjuv
properti
increas
efficaci
antibodi
product
immun
respons
immun
probiot
mediat
effect
increas
transport
antigen
materi
across
gut
mucosa
upregul
antigenpres
molecul
costimulatori
molecul
immun
cell
gill
prasad
hakansson
molin
import
compon
immun
respons
mediat
cytokin
largest
pleiotrop
group
mediat
respons
initi
mainten
resolut
innat
acquir
immun
respons
sever
studi
demonstr
abil
specif
probiot
strain
enhanc
cytokin
product
influenc
innat
acquir
immun
respons
probiot
administr
report
enhanc
level
ifng
ifna
healthi
subject
arunachalam
gill
chandra
longterm
consumpt
probiot
contain
yogurt
shown
increas
product
ifng
tnfa
tgfb
mononuclear
cell
dendrit
cell
cross
gill
guarner
nier
et
al
sever
studi
provid
direct
evid
administr
specif
probiot
strain
help
prevent
treatment
gastrointestin
infect
studi
conduct
anim
also
demonstr
abil
probiot
enhanc
serum
mucos
antibodi
phagocyt
cell
function
modern
approach
probiot
research
control
foodborn
pathogen
nk
cell
activ
resist
infect
pathogen
gill
prasad
hakansson
molin
tabl
probiot
exert
antimicrobi
cytoprotect
effect
host
intestin
epithelium
directli
product
antimicrobi
factor
indirectli
increas
express
host
cell
antimicrobi
peptid
enhanc
barrier
function
immunomodul
section
specif
discuss
antimicrobi
produc
probiot
antagonist
effect
pathogen
intestin
cell
produc
two
main
class
antimicrobi
peptid
name
defensin
cathelicidin
cathelicidin
constitut
produc
intestin
epitheli
cell
aid
host
defens
pathogen
kelsal
stimulu
appear
induc
cathelicidin
product
butyr
produc
intestin
flora
schauber
et
al
also
probiot
floch
sunkara
et
al
shigella
infect
dysenteri
rabbit
significantli
reduc
feed
butyr
induc
cathelicidin
product
raqib
et
al
defensin
produc
intestin
cell
classifi
adefensin
bdefensin
adefensin
produc
small
bowel
paneth
cell
bdefensin
express
epitheli
cell
throughout
intestin
defensin
exhibit
antimicrobi
activ
wide
varieti
bacteria
fungi
virus
defensin
constitut
produc
intestin
keep
pathogen
reach
epithelium
wehkamp
et
al
vitro
studi
probiot
demonstr
cell
upon
stimul
e
coli
nissl
e
coli
strain
dsm
sever
lactobacilli
cocktail
vsl
led
increas
express
secret
human
b
schlee
et
al
wehkamp
et
al
underli
mechan
probiot
stimul
product
elucid
use
specif
inhibitor
observ
secret
enhanc
activ
map
kinas
schlee
et
al
besid
activ
map
kinas
also
observ
e
coli
nissl
flagellin
also
stimul
product
schlee
et
al
addit
stimul
product
host
antimicrobi
peptid
probiot
produc
sever
antimicrobi
compound
bactericid
peptid
scfa
directli
inactiv
pathogen
dobson
et
al
hassan
et
al
secret
factor
consid
integr
part
intestin
barrier
scfa
includ
acet
lactic
acid
reduc
lumin
ph
result
growth
inhibit
pathogen
includ
enterohemorrhag
e
coli
ehec
salmonella
enterica
serovar
typhimurium
vitro
addit
scfa
produc
probiot
also
shown
decreas
shiga
toxin
gene
express
e
coli
carey
kostrzynska
ojha
thompson
fayolmessaoudi
berger
coconnierpolt
lievinl
moal
servin
furthermor
scfa
also
disrupt
outer
membran
gramneg
pathogen
ehec
pseudomona
aeruginosa
typhimurium
therebi
inhibit
pathogen
growth
increas
permeabil
outer
membran
pathogen
also
potenti
activ
antimicrobi
modern
approach
probiot
research
control
foodborn
pathogen
molecul
aid
penetr
cell
wall
alakomi
et
al
besid
lactic
acid
predomin
antimicrobi
activ
lactobacilli
product
antimicrobi
peptid
bacteriocin
microcin
fayolmessaoudi
et
al
bacteriocin
microcin
peptid
bactericid
bacteriostat
activ
produc
strainspecif
manner
probiot
lievinl
moal
servin
bacteriocin
peptid
produc
gramposit
bacteria
microcin
produc
gramneg
bacteria
bacteriocin
permeabil
cytoplasm
membran
bacteria
lead
disrupt
cell
wall
synthesi
format
pore
eventu
lead
cell
death
microcin
hand
target
enzym
involv
dna
rna
structur
synthesi
protein
synthesi
enzym
duquesn
petit
peduzzi
rebuffat
collect
antimicrobi
compound
protect
intestin
barrier
rapidli
elimin
pathogen
gut
bacteriocin
produc
l
salivariu
shown
inhibit
growth
bacillu
listeria
staphylococcu
enterococcu
speci
howev
bacteriocin
affect
growth
lactobacillu
speci
therebi
provid
select
advantag
intestin
colon
probiot
commens
bacteria
flynn
et
al
similarli
lacticin
produc
l
lacti
shown
clostridium
difficil
potenti
therapi
howev
bacteriocin
inhibit
resid
bacteria
includ
lactobacillu
bifidobacteria
rea
et
al
separ
studi
banerje
merkel
bhunia
show
solubl
factor
produc
probiot
lactobacillu
delbrueckii
subsp
bulgaricu
abl
neutral
c
difficil
toxin
therebi
prevent
cytotox
cell
cultur
model
l
delbrueckii
demonstr
produc
hydrogen
peroxid
inactiv
pathogen
oxid
l
delbrueckii
also
produc
lactic
acid
heatsensit
heatresist
bacteriocin
heatresist
bacteriocin
observ
inhibit
growth
thermophilu
van
de
gucht
ehrlich
maguin
similarli
certain
bifidobacterium
strain
produc
lipophil
molecul
shown
inhibit
viabil
e
coli
klebsiella
pneumonia
yersinia
pseudotuberculosi
aureu
typhimurium
addit
antimicrobi
compound
also
demonstr
prevent
invas
cell
typhimurium
also
kill
intracellular
typhimurium
therapeut
model
lievin
et
al
probiot
also
exert
antimicrobi
cytoprotect
effect
inhibit
pathogen
adher
intestin
epithelium
collado
isolauri
salminen
sanz
sherman
ossa
johnsonhenri
probiot
inhibit
pathogen
adher
compet
bind
site
epitheli
cell
pretreat
cell
line
l
rhamnosu
l
acidophilu
significantli
reduc
bind
enteropathogen
e
coli
epec
ehec
monolay
addit
probiot
pretreat
also
reduc
ehecinduc
increas
permeabl
help
maintain
monolay
integr
johnsonhenri
donato
shentu
gordanpour
sherman
sherman
et
al
probiot
bacteria
cell
surfac
compon
also
inhibit
e
coli
adhes
cell
johnsonhenri
hagen
gordonpour
tompkin
sherman
medellinpena
griffith
virulenceassoci
gene
express
medellinpena
wang
johnson
anand
griffith
lactobacillu
strain
also
shown
compet
directli
pathogen
salmonella
speci
bind
site
human
mucin
cell
surfac
gueimond
jalonen
hiramatsu
salminen
besid
physic
displac
pathogen
e
coli
nissl
shown
secret
nonbacteriocin
compon
may
act
either
pathogen
host
cell
inhibit
adher
sever
pathogen
altenhoef
et
al
similar
studi
perform
rat
model
suffer
chronic
psycholog
stress
administ
l
rhamnosu
l
helveticu
demonstr
reduc
commens
bacteri
adher
transloc
zarei
et
al
thu
inhibit
pathogen
adher
anoth
mechan
probiot
bacteria
prevent
intestin
infect
altogeth
probiot
exert
cytoprotect
effect
intestin
tract
abil
enhanc
intestin
barrier
function
immun
modul
toxin
bind
neutral
inactiv
prevent
pathogen
attach
tabl
probiot
administ
oral
first
encount
variou
harsh
environ
gut
therefor
essenti
probiot
surviv
intestin
tract
signific
number
produc
benefici
effect
surviv
probiot
depend
multipl
factor
stress
respons
metabol
ph
homeogenesi
cell
wall
mainten
fatti
acid
synthesi
breton
et
al
sander
gramposit
probiot
bacteria
use
sever
mechan
help
surviv
gut
includ
proton
pump
amino
acid
decarboxyl
electrogen
transport
system
aid
acid
resist
chang
structur
cell
envelop
chaperon
involv
repair
damag
protein
increment
express
regul
promot
global
gene
respons
cotter
hill
addit
sever
probiot
also
shown
modul
gene
express
vitro
simul
gastrointestin
tract
environ
vivo
mous
model
bron
grangett
merceni
de
vo
kleerebezem
bron
molenaar
vo
kleerebezem
probiot
surviv
transit
stomach
intestin
interact
major
compon
gastrointestin
tract
resid
commens
flora
consist
differ
microbi
speci
collado
et
al
one
earliest
investig
interact
probiot
resid
microbiota
tannock
et
al
reveal
administr
l
rhamnosu
result
modest
fluctuat
resid
lactobacillu
bifidobacterium
number
subject
ceas
shed
probiot
strain
administr
stop
howev
one
subject
continu
shed
probiot
strain
month
test
period
indic
interhost
variabl
bacteriumhost
interact
probiot
commonli
appli
companion
farm
anim
growth
enhanc
patterson
burkhold
swanson
fahey
demonstr
administr
cocktail
lactobacilli
bifidobacteria
enterococci
pediococci
improv
weight
gain
broiler
chicken
associ
increas
bifidobacterium
lactobacilli
gramposit
cocci
popul
mountzouri
et
al
similar
studi
piglet
administ
enterococcu
faecium
strain
reduc
enterococcu
faecali
popul
intestin
wean
pig
total
number
e
faecium
remain
unchang
suggest
e
faecium
strain
introduc
displac
part
speci
vahjen
tara
simon
anoth
studi
perform
mice
demonstr
administr
l
casei
l
plantarum
affect
overal
divers
murin
intestin
lactobacilli
overal
bacteri
commun
structur
fuent
et
al
furthermor
increas
popul
lactobacilli
relat
acidophilu
complex
observ
use
anim
model
provid
us
insight
interact
probiot
resid
flora
howev
studi
human
essenti
speci
desir
host
studi
done
human
alter
gut
microflora
report
human
irrit
bowel
syndrom
ib
kassinen
et
al
satokari
et
al
administr
multispeci
probiot
supplement
abl
allevi
ib
stabil
gut
microbiota
time
kajand
et
al
besid
treat
inflammatori
condit
probiot
also
efficaci
treatment
infecti
diarrhea
benchimol
mack
guandalini
guandalini
sever
way
probiot
alter
microbiota
includ
competit
nutrient
chang
microenviron
product
growth
substrat
direct
antagon
competit
exclus
barrier
function
immun
stimul
reduct
inflamm
otool
cooney
studi
use
transcript
microarray
shown
introduc
probiot
mous
gut
chang
metabol
pathway
endogen
microbiota
sonnenburg
chen
gordon
gnotobiot
mice
colon
bacteroid
thetaiotaomicron
challeng
b
animali
l
casei
result
shift
gene
express
pattern
b
thetaiotaomicron
mani
alter
gene
found
involv
carbohydr
metabol
sonnenburg
et
al
suggest
probiot
alter
resid
microbiota
popul
gene
express
competit
substrat
avail
alter
dynam
carbohydr
util
keeney
finlay
probiot
also
alter
microenviron
microbiota
divers
rang
metabol
pathway
outcom
colon
germfre
mice
microbiota
human
babi
expos
lactobacilli
strain
result
microbiom
modif
measur
select
cultur
regim
clau
et
al
also
associ
chang
fecal
level
cholin
acet
ethanol
unconjug
bile
acid
cecal
concentr
scfa
besid
chang
microenviron
sever
probiot
strain
also
known
produc
vitamin
growth
factor
enhanc
avail
growth
factor
also
modul
divers
intestin
microbiota
probiot
bacteria
also
impact
resid
microbiota
direct
antagon
natur
competit
probiot
opportunist
pathogen
could
also
mediat
product
bacteriocin
exploit
modul
microbiota
indirect
mechan
probiot
modul
inher
microbiota
includ
enhanc
intestin
barrier
function
alter
releas
rate
hostderiv
micronutri
suppress
proinflammatori
cytokin
result
reduct
gut
inflamm
zyrek
et
al
reduct
inflamm
alter
gut
environ
suffici
impact
microbiota
addit
administr
probiot
also
bolster
innat
acquir
immun
respons
lead
subtl
chang
overal
composit
gut
microbiota
gill
rutherfurd
adequ
inform
literatur
indic
administr
probiot
high
dosag
impact
divers
gut
microflora
preidi
et
al
howev
detail
studi
requir
understand
interplay
diet
microbiota
host
factor
determin
outcom
allow
manipul
foodborn
pathogen
major
concern
worldwid
due
increas
mortal
morbid
flint
et
al
thu
variou
afford
intervent
strategi
includ
improv
foodprocess
method
along
probioticbas
natur
function
food
system
must
develop
protect
peopl
foodborn
infect
probiot
live
nonpathogen
microorgan
administ
maintain
improv
intestin
microbi
balanc
also
protect
consum
untoward
infect
pathogen
among
variou
etiolog
agent
bacteri
viral
mycotoxin
major
concern
sever
studi
demonstr
efficaci
either
wildtyp
recombin
probiot
foodborn
pathogen
therebi
help
improv
anim
health
prevent
foodborn
infect
bhunia
dobson
et
al
salminen
et
al
section
discuss
variou
probioticbas
intervent
strategi
control
foodborn
pathogen
mechan
probioticmedi
antimicrobi
action
gastrointestin
tract
illustr
fig
feren
hovd
soon
et
al
among
mani
intervent
strategi
investig
probiot
found
effect
lema
william
rao
demonstr
efficaci
sever
probiot
includ
l
acidophilu
l
casei
l
fermentum
l
plantarum
e
faecium
reduc
e
coli
shed
sheep
microbi
supplement
fed
freezedri
ferment
product
probiot
period
week
anim
group
fed
probiot
supplement
show
significantli
lower
number
e
coli
shed
fece
increas
averag
daili
weight
gain
feed
convers
addit
reduc
fecal
shed
administr
bifidobacteria
mice
show
decreas
shiga
toxin
product
mice
fed
bifidobacterium
breve
signific
reduct
bodi
weight
loss
mortal
compar
control
group
demonstr
b
breve
capabl
protect
mice
e
coli
infect
asahara
et
al
studi
conduct
stephen
loneragan
karunasena
brashear
also
demonstr
directf
probiot
consist
l
acidophilu
differ
dose
led
dosedepend
decreas
fecal
shed
presenc
hide
addit
use
lactobacillu
studi
use
nonpathogen
e
coli
e
coli
nissl
strain
also
inhibit
bacteri
growth
shiga
toxin
product
stec
reissbrodt
et
al
studi
use
vitro
cell
cultur
model
also
use
elucid
efficaci
probiot
control
e
coli
sherman
et
al
intestin
cell
monolay
expos
l
acidophilu
l
rhamnosu
follow
infect
ehec
epec
e
coli
e
coli
respect
follow
infect
adher
cytotox
induc
ehec
epec
examin
exposur
probiot
strain
significantli
reduc
pathogen
attach
monolay
addit
probiot
also
protect
monolay
pathogeninduc
loss
transepitheli
resist
tight
junction
integr
besid
reduc
adher
cell
injuri
l
acidophilu
cellfre
spent
media
result
downregul
sever
virul
gene
involv
colon
ehec
medellinpena
et
al
similar
studi
conduct
use
e
coli
balbc
mice
demonstr
preexposur
l
paracasei
result
upregul
dendrit
cell
helper
cell
antibodi
product
downregul
proinflammatori
cytokin
yield
enhanc
protect
intestin
integr
tsai
cheng
pan
addit
use
wildtyp
probiot
paton
et
al
gener
recombin
nonpathogen
e
coli
carri
chimer
lipopolysaccharid
capabl
bind
enterotoxin
produc
enterotoxigen
e
coli
etec
recombin
probiot
abl
neutral
enterotoxin
cultur
lysat
divers
etec
strain
similarli
recombin
l
casei
strain
carri
fimbria
etec
abl
reduc
attach
etec
porcin
intestin
brush
border
dosedepend
manner
reduc
infect
mice
model
wen
et
al
studi
demonstr
bioengin
probiot
use
target
control
specif
enteropathogen
salmonella
infect
lead
caus
foodborn
gastroenter
human
worldwid
commonli
associ
raw
uncook
poultri
egg
fruit
veget
foley
lynn
nayak
weill
et
al
unit
state
nontyphoid
salmonella
respons
total
foodborn
ill
hospit
scallan
et
al
salmonella
util
numer
virul
factor
initi
infect
colon
effect
epitheli
cell
gut
ahmer
gunn
therefor
control
strategi
appli
along
food
product
chain
prevent
entri
human
food
suppli
vandepla
duboi
dauphin
becker
thonart
sever
studi
demonstr
inocul
cultur
one
sever
probiot
strain
broiler
chicken
may
inhibit
salmonella
contamin
audisio
oliv
apella
higgin
et
al
higgin
et
al
van
coilli
et
al
neonat
broiler
chick
challeng
salmonella
enteritidi
challeng
lactobacillu
probiot
cultur
differ
dose
oral
lactobacillu
significantli
reduc
salmonella
incid
chick
higgin
et
al
similar
studi
conduct
grower
pig
challeng
enterica
serotyp
typhimurium
administ
l
plantarum
result
reduct
fecal
shed
pathogen
addit
probiot
feed
also
improv
perform
pig
gebru
et
al
l
rhamnosu
also
abl
reduc
epitheli
cell
stress
induc
heat
cytotox
induc
typhimurium
infect
cultur
epitheli
cell
model
burkhold
bhunia
commerci
avail
probiot
cocktail
evalu
abil
inhibit
salmonella
colon
neonat
broiler
chicken
turkey
poult
administr
probiot
cultur
floramax
ivswynco
llc
springdal
ar
significantli
reduc
salmonella
count
tonsil
ceca
chicken
poult
menconi
et
al
furthermor
administr
lactobacillu
reuteri
strain
produc
reuterin
bacteriocin
significantli
reduc
salmonella
popul
increas
surviv
rate
chick
zhang
li
li
probiot
bacillu
subtili
dsm
also
abl
significantli
reduc
cecal
load
salmonella
knap
et
al
vitro
gut
ferment
cellular
model
use
evalu
protect
effect
probiot
salmonella
addit
bacillu
thermophilu
salmonella
reactor
colon
ferment
model
reveal
protect
effect
epitheli
integr
increas
transepitheli
resist
zihler
gagnon
chassard
lacroix
probiot
also
effect
antibioticresist
typhimurium
administr
l
casei
shirota
mice
challeng
typhimurium
significantli
reduc
pathogen
growth
subsequ
extraintestin
dissemin
increas
concentr
organ
acid
lower
ph
intestin
thought
reduc
probiot
colon
correl
antimicrobi
activ
mechan
underli
antibacteri
effect
lactobacillu
multifactori
involv
lower
ph
product
lactic
acid
product
bacteriocin
nonbacteriocin
nonlact
compound
dobson
et
al
observ
l
johnsonii
l
rhamnosu
gg
l
casei
shirota
l
casei
l
rhamnosu
dramat
reduc
viabil
enterica
serovar
typhimurium
product
nonlact
acid
molecul
complet
inhibit
salmonella
growth
observ
due
phlower
effect
fayolmessaoudi
et
al
anoth
studi
solubl
factor
produc
b
bifidum
also
suppress
gene
express
typhimurium
requir
adhes
invas
system
spread
bayoumi
griffith
vivo
studi
use
mous
model
demonstr
continu
administr
l
casei
crl
diminish
salmonella
count
intestin
well
spread
outsid
organ
probioticassoci
immunomodulatori
effect
involv
innat
adapt
immun
respons
probiot
administr
reduc
neutrophil
infiltr
activ
phagocyt
activ
increas
cell
releas
siga
specif
pathogen
intestin
fluid
de
leblanc
castillo
perdigon
besid
antimicrobi
action
probiot
also
increas
feed
convers
perform
chicken
turkey
poult
poultri
campylobact
anoth
predomin
bacteri
pathogen
respons
numer
outbreak
sever
probiot
strain
evalu
efficaci
control
campylobact
human
colon
embryon
epitheli
cell
pretreat
lactobacillu
strain
infect
c
jejuni
observ
l
helveticu
reduc
c
jejuni
invas
cell
cell
respect
addit
l
helveticu
adher
effici
epitheli
cell
suggest
inhibit
pathogen
invas
could
due
competit
exclus
wine
gareau
johnsonhenri
sherman
vivo
experi
conduct
use
defin
human
microbiotaassoci
balbc
mice
oral
infect
either
c
jejuni
salmonella
subsequ
challeng
probiot
lactobacilli
bifidobacteria
probiot
abl
enhanc
colon
resist
success
exclud
pathogen
mice
also
increas
prolifer
lymphocyt
salmonella
antigen
studi
indic
probiot
administr
revers
immunosuppress
activ
salmonella
balbc
mice
wagner
johnson
rubin
baffoni
et
al
evalu
use
synbiot
control
c
jejuni
poultri
prebiot
galactooligosaccharid
use
probiot
b
longum
subsp
longum
synbiot
significantli
reduc
c
jejuni
popul
poultri
fece
therebi
highlight
posit
effect
employ
synbiot
approach
reduc
pathogen
load
among
variou
pathogen
caus
foodborn
ill
hospit
death
listeria
respons
associ
death
scallan
et
al
upon
arriv
gastrointestin
tract
l
monocytogen
invad
intestin
epithelium
dissemin
mesenter
lymph
node
spleen
liver
vazquezboland
et
al
bacteremia
organ
reach
liver
spleen
gall
bladder
brain
placenta
placenta
caus
villou
necrosi
microabscess
result
preterm
abort
infect
fetu
lead
stillbirth
neonat
listeriosi
bakardjiev
theriot
portnoy
jiao
et
al
sever
probiot
evalu
abil
control
l
monocytogen
infect
do
santo
et
al
evalu
monoassoci
l
delbrueckii
gnotobiot
mice
effect
listeria
colon
administr
l
delbrueckii
capabl
protect
mice
death
caus
l
monocytogen
also
led
faster
clearanc
bacteria
variou
organ
liver
spleen
periton
caviti
gut
addit
probioticf
mice
also
show
increas
ifng
signifi
role
effector
molecul
probioticinduc
cytoprotect
similar
result
obtain
studi
rat
fed
l
casei
shirota
strain
addit
reduc
listeria
popul
gut
spleen
liver
fece
probiot
strain
also
increas
cellular
immun
determin
delayedtyp
hypersensit
respons
heatkil
l
monocytogen
de
waard
garssen
bokken
vo
puertollano
et
al
evalu
immunomodulatori
effect
l
plantarum
l
monocytogen
infect
mice
administr
l
plantarum
mice
infect
l
monocytogen
result
reduct
product
proinflammatori
cytokin
circumv
listeriamedi
cytotox
sever
speci
lactobacillu
bifidobacterium
also
abl
inhibit
l
monocytogen
infect
cell
cultur
model
later
antiinfect
properti
probiot
l
salivariu
shown
due
product
bacteriocin
protect
mice
listeriosi
challeng
l
monocytogen
corr
li
et
al
addit
use
wildtyp
probiot
koo
amalaradj
bhunia
gener
recombin
l
paracasei
strain
control
l
monocytogen
infect
cell
cultur
model
recombin
probiot
design
express
listeria
adhes
protein
essenti
virul
factor
burkhold
bhunia
jagadeesan
et
al
aid
listeria
transepitheli
transloc
intestin
phase
infect
preexposur
intestin
monolay
recombin
probiot
follow
listeria
infect
led
reduct
adhes
paracellular
transloc
respect
recombin
probiot
also
protect
monolay
listeriamedi
cytotox
tight
junction
compromis
use
recombin
probiot
help
target
elimin
enter
pathogen
probiot
evalu
control
c
perfringen
turkey
poult
rahimi
kathari
grime
siletzki
administr
primalac
commerci
probiot
cocktail
turkey
poult
significantli
reduc
cecal
c
perfringen
count
compar
control
anoth
studi
recombin
pichia
pastori
contain
c
perfringen
alpha
toxin
gene
significantli
increas
weight
gain
feed
effici
sero
convers
absenc
advers
reaction
histopatholog
evalu
broiler
chick
gil
de
lo
santo
storch
fernand
gilturn
probiot
bacteria
also
use
control
vibrio
parahaemolyticu
attach
cell
cultur
model
l
plantarum
shown
attach
effici
cell
reduc
v
parahaemolyticu
attach
competit
exclus
displac
satish
kumar
et
al
recombin
probiot
express
chimer
lipopolysaccharid
abl
bind
cholera
toxin
protect
infant
mice
challeng
virul
v
cholera
focareta
paton
morona
cook
paton
probiot
also
shown
effect
pathogen
shigella
sonnei
aureu
e
faecali
proteu
mirabili
p
aeruginosa
varma
dinesh
menon
biswa
probiot
also
use
control
viral
infect
gnotobiot
pig
fed
l
acidophilu
l
reuteri
enhanc
ifng
respons
serum
decreas
human
rotaviru
infect
wen
et
al
protect
rotavirusinduc
diarrhea
also
induc
administr
l
paracasei
express
variabl
domain
llama
heavychain
antibodi
fragment
pant
et
al
anoth
major
enter
viru
respons
foodborn
ill
noroviru
marshal
bruggink
mattison
probioticfer
milk
contain
l
casei
shirota
strain
evalu
efficaci
control
noroviru
gastroenter
health
servic
facil
total
peopl
enrol
studi
intak
probioticfer
milk
treatment
group
result
reduct
mean
durat
fever
onset
gastroenter
nagata
et
al
wang
yu
gao
yang
gener
recombin
lactobacillu
strain
express
hemagglutinin
avian
influenza
viru
oral
administr
recombin
probiot
balbc
mice
trigger
mucos
system
immun
respons
increas
antiha
iga
antiha
igg
level
associ
increas
product
recombin
l
casei
express
human
lactoferrin
shown
exhibit
antibacteri
antivir
activ
vitro
vivo
model
chen
et
al
receptor
mimet
use
strategi
control
foodborn
pathogen
mani
enter
pathogen
recogn
oligosaccharid
express
host
cell
receptor
toxin
adhes
factor
interact
ligand
receptor
essenti
initi
infect
process
critic
step
infect
process
adapt
develop
intervent
strategi
involv
express
molecular
mimic
host
oligosaccharid
probiot
bacteria
control
enter
pathogen
paton
morona
paton
design
probiot
bind
bacteri
toxin
competit
inhibit
pathogen
bind
receptor
gut
receptor
mimic
probiot
develop
stec
etec
paton
et
al
cholera
focareta
et
al
c
jejuni
yuki
et
al
addit
enter
pathogen
probiot
also
develop
mani
pathogen
infecti
agent
summar
tabl
fungal
pathogen
could
control
inactiv
toxin
mycotoxin
caus
foodborn
infect
mycotoxin
clinic
import
due
abil
induc
acut
chronic
toxic
host
kabak
dobson
var
mycotoxin
mutagen
carcinogen
teratogen
immunosuppress
natur
salminen
et
al
probiot
known
bind
neutral
toxin
attribut
probiot
exploit
reduct
dietari
exposur
fungal
toxin
specif
strain
probiot
prove
highli
effect
remov
mycotoxin
model
system
armando
et
al
demonstr
saccharomyc
cerevisia
strain
adsorb
ochratoxin
zearalenon
mycotoxin
bind
assay
simul
gastrointestin
condit
also
observ
toxin
bind
function
cell
wall
thick
bind
occur
physic
adsorpt
similar
studi
conduct
use
food
system
grape
juic
also
demonstr
abil
saccharomyc
strain
adsorb
ochratoxin
bejaoui
mathieu
taillandi
lebrihi
rat
fed
aflatoxincontain
diet
show
administr
lactobacilli
casei
l
reuteri
significantli
reduc
oxid
stress
induc
aflatoxin
comparison
control
group
receiv
probiot
hathout
et
al
similar
experi
conduct
rat
fed
differ
dose
aflatoxin
follow
administr
l
reuteri
demonstr
significantli
lower
level
intestin
control
group
studi
demonstr
probiot
strain
bind
toxin
intestin
act
barrier
toxininduc
cell
cytotox
hernandezmendoza
vallejocordoba
garcia
besid
aflatoxin
ochratoxin
zearalenon
fungal
toxin
patulin
fumonisin
also
neutral
probiot
buccato
et
al
adapt
well
merceni
sever
probiot
strain
propionibacterium
l
rhamnosu
gg
l
plantarum
l
casei
bacillu
speci
e
faecium
demonstr
bind
neutral
mycotoxin
danick
doll
hernandezmendoza
garcia
steel
hernandezmendoza
et
al
khanafari
soudi
miraboulfathi
osboo
niderkorn
morgavi
aboab
lemair
boudra
topcu
bulat
wishah
boyaci
use
probiot
control
infect
essenti
surviv
acid
gastric
ph
intestin
enzym
bile
alkalin
ph
abl
exert
protect
effect
critic
use
recombin
probiot
ensur
product
foreign
protein
target
site
gener
probiot
supplement
deliv
capsul
tablet
powder
choic
deliveri
matrix
also
import
ensur
probiot
activ
viabil
hajela
nair
abraham
ganguli
probiot
encapsul
technolog
pet
emerg
princip
method
deliveri
probiot
wide
rang
microb
immobil
use
semiperm
biocompat
materi
modul
deliveri
releas
probiot
either
entrap
encapsul
entrap
refer
trap
materi
within
throughout
matrix
encapsul
involv
format
continu
coat
around
inner
matrix
present
within
capsul
wall
core
encapsul
materi
encapsul
help
stabil
cell
enhanc
viabil
stabil
product
storag
handl
pet
help
control
continu
deliveri
probiot
cell
gut
biomateri
use
encapsul
probiot
includ
algin
carrageenan
gelatin
chitosan
whey
protein
cellulos
acet
phthalat
locust
bean
gum
starch
anal
singh
chandramouli
kailasapathi
peiri
jone
krasaekoopt
bhandari
deeth
algin
gel
insolubl
acid
media
henc
protect
probiot
gastric
acid
gbassi
vandamm
ennahar
marchioni
carrageenan
use
abil
form
gel
entrap
probiot
bacteria
doleyr
fliss
lacroix
doleyr
paquin
leroy
lacroix
cellulos
acet
phthalat
insolubl
ph
solubl
ph
greater
especi
advantag
stabil
encapsul
probiot
stomach
control
releas
intestin
anal
singh
microencapsul
probiot
perform
freezedri
extrus
emulsif
freezedri
result
format
concentr
dri
powder
longer
shelf
life
protect
probiot
gastric
fluid
bile
rokka
rantamaki
essenti
provid
probiot
physic
barrier
protect
advers
condit
encount
gut
purpos
extrus
emulsif
techniqu
intend
develop
gel
bead
capsul
appli
lacroix
paquin
arnaud
extrus
techniqu
involv
mixtur
probiot
hydrocolloid
final
result
format
gell
droplet
call
bead
gouin
emulsif
involv
mixtur
probiot
continu
phase
result
waterinoil
emuls
techniqu
use
develop
encapsul
probiot
shima
morita
yamashita
adachi
emulsif
result
format
oili
aqueou
droplet
call
capsul
gbassi
vandamm
algin
microcapsul
coat
chitosan
evalu
abil
increas
gastrointestin
viabil
b
breve
chitosan
stabil
algin
microcapsul
ph
coat
chitosan
also
increas
surviv
b
breve
simul
gastric
fluid
prolong
releas
upon
exposur
intestin
ph
cook
tzortzi
charalampopoulo
khutoryanskiy
calinescu
mateescu
develop
tablet
dosag
system
base
carboxyl
methyl
high
amylos
starch
cmha
chitosan
excipi
probiot
colon
deliveri
cmha
ensur
protect
gastric
ph
chitosan
help
slow
releas
probiot
intestin
encapsul
l
rhamnosu
result
improv
percentag
deliv
bacteria
simul
intestin
condit
enhanc
slow
sustain
releas
probiot
gut
coacerv
extendedreleas
microparticul
deliveri
system
develop
alli
core
mucoadhes
l
rhamnosu
prepar
use
hypermellos
subsequ
enter
coat
hypermellos
phthalat
hypermellos
good
mucoadhes
releas
rate
control
properti
prefer
mucoadhes
formul
use
microparticl
simul
intestin
condit
exhibit
appreci
mucoadhes
compar
freezedri
cultur
addit
use
abovement
matric
dnabas
gel
also
evalu
vehicl
oral
deliveri
probiot
dnabas
gel
initi
prepar
protect
lactic
acid
bacteria
extrem
condit
commerci
yogurt
jonganurakkun
liu
nodasaka
nomizu
nishi
jonganurakkun
nodasaka
sakairi
nishi
dna
form
complex
gell
agent
gelatin
kcarrageenan
low
ph
result
format
two
kind
gel
hydrogel
complex
gel
hydrogel
bacteria
fix
gel
yogurt
contain
bacteria
ad
precool
mixtur
dna
gell
agent
complex
gel
mixtur
yogurt
cacao
oil
ad
gel
solut
contain
dna
gell
agent
form
encapsul
probiot
seen
complex
gel
abl
protect
probiot
advers
simul
gastric
condit
hydrogel
addit
protect
acid
condit
also
stabl
c
storag
correspond
storag
temperatur
product
would
maintain
prolong
storag
jonganurakkun
et
al
thu
dnabas
hydrogel
offer
potenti
deliveri
system
oral
administr
probiot
probiot
extens
studi
vitro
vivo
model
ampl
evid
document
support
potenti
applic
probiot
prevent
treatment
enter
infect
health
benefit
probiot
includ
prevent
diarrhea
atop
eczema
antibioticassoci
diarrhea
travel
diarrhea
prevent
dental
carri
colorect
cancer
treatment
ibd
howev
potenti
intervent
strategi
probiot
also
safeti
concern
therefor
essenti
toxic
metabol
effect
probiot
human
assess
patient
safeti
especi
critic
ill
immunocompromis
patient
signific
challeng
still
exist
effect
applic
probiot
pathogen
control
futur
studi
essenti
defin
optim
dose
correct
combin
variou
probiot
speci
base
molecular
mode
antimicrobi
action
also
need
improv
product
techniqu
understand
develop
better
approach
probiot
deliveri
bioavail
gut
move
theoret
benefit
clinic
applic
possibl
express
differ
molecul
probiot
bacteria
enzym
cytokin
receptor
mimic
adhes
molecul
antibodi
host
target
molecul
futur
research
help
optim
applic
develop
biolog
contain
strain
support
clinic
trial
thu
probiot
bacteria
use
control
prevent
pathogen
colon
food
anim
improv
food
safeti
realist
therapeut
option
human
control
enter
pathogen
